Publications

Below are articles published in medical journals that have resulted from TSF-funded research

MOG CNS Autoimmunity and MOGAD

Carson E. Moseley, Akash Virupakshaiah, Thomas G. Forsthuber, Lawrence Steinman, Emmanuelle Waubant and Scott S. Zamvil.

Neurol Neuroimmunol Neuroinflamm – July 2024

Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide

Jyh Yung Hor and Kazuo Fujihara

Frontiers in Neurology – September 2023

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis

Benjamin Vlad, Ina Reichen, Stephan Neidhart, Marc Hilty, Dimitra Lekaditi, Christine Heuer, Amanda Eisele, Mario Ziegler, Markus Reindl, Andreas Lutterotti, Axel Regeniter and Ilijas Jelcic

Frontiers in Neurology – September 2023

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease

Elena Grebenciucova, Gina S. Perez Giraldo and Natalia Gonzalez Caldito

Frontiers in Neurology – July 2023

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders

Yoshiki Takai, Tatsuro Misu, Kazuo Fujihara and Masashi Aoki

Frontiers in Neurology – July 2023

Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody

Xu M. Hui, Ma Chi, Ming Dong, Liu Yue and Wang Xu

Frontiers in Immunology – July 2023

High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting

Tammy L. Smith, Thomas R. Haven, Lauren M. Zuromski, Kyphuong Luong, Stacey L. Clardy and Lisa K. Peterson

Frontiers in Neurology – July 2023

Investigating the association between neoplasms and MOG antibody-associated disease

Milena Trentinaglia, Alessandro Dinoto, Sara Carta, Vanessa Chiodega, Sergio Ferrari, Vincenzo Andreone, Giorgia Teresa Maniscalco and Sara Mariotto

Frontiers in Neurology – June 2023

Pediatric myelin oligodendrocyte glycoprotein antibody-associated disease in southern China: analysis of 93 cases

Xiaojing Li, Wenlin Wu, Chi Hou, Yiru Zeng, Wenxiao Wu, Lianfeng Chen, Yinting Liao, Haixia Zhu, Yang Tian, Bingwei Peng, Kelu Zheng, Kaili Shi, Ying Li, Yuanyuan Gao, Yani Zhang, Haisheng Lin and Wen-Xiong Chen

Frontiers in Immunology – June 2023

Helicobacter pylori infection may influence prevalence and disease course in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) similar to MS but not AQP4-IgG associated NMOSD

Chaithra Malli, Lekha Pandit, Anita D’Cunha and Akshatha Sudhir

Frontiers in Immunology – May 2023

Understanding the employment impact of neuromyelitis optica spectrum disorder in the USA: Mixed methods

Farrah Mateen and Cristina Trápaga Hacker

Frontiers in Neurology – March 2023

Therapeutic response in pediatric neuromyelitis optica spectrum disorder

Raffaella Pizzolato Umeton, Michael Waltz, Gregory S. Aaen, Leslie Benson, Mark Gorman, Manu Goyal, Jennifer S. Graves, Yolanda Harris, Lauren Krupp, Timothy E. Lotze, Nikita M. Shukla, Soe Mar, Jayne Ness, Mary Rensel, Teri Schreiner, Jan-Mendelt Tillema, Shelly Roalstad, Moses Rodriguez, John Rose, Emmanuelle Waubant, Bianca Weinstock-Guttman, Charles Casper, Tanuja Chitnis, on behalf of the US Network of Pediatric MS Centers

Neurology – February 2023

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease

Osman Corbali and Tanuja Chitnis

Frontiers in Neurology – February 2023

Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study

Yanlin Lang, William Robert Kwapong, Lingyao Kong, Ziyan Shi, Xiaofei Wang, Qin Du, Bo Wu, Hongyu Zhou

Frontiers in Neurology – January 2023

Volumetric brain changes in MOGAD: A cross-sectional and longitudinal comparative analysis

Itay Lotan, Thibo Billiet, Annemie Ribbens, Wim Van Hecke, Benny Huang, Ilya Kister and Eyal Lotan

Multiple Sclerosis and Related Disorders – January 2023

Treatment outcomes of first-ever episode of severe optic neuritis

Kristin Galetta, Sophia Ryan, Giovanna Manzano, Lori B. Chibnik, Denis Balaban, Sashank Prasad, Bart K. Chwalisz, Andrea Salazar-Camelo, Sarah Conway, Michael Levy and Marcelo Matiello

Multiple Sclerosis and Related Disorders – October 2022

A point-of-care diagnostic test for aquaporin-4 antibody seropositive neuromyelitis optica

Dylan R. Rice, Shuhei Nishiyama, Santiago Pardo, Ana M. Cabal Herrera, Michael Levy and Farrah Mateen

Multiple Sclerosis and Related Disorders – April 2022

Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4

Lekha Pandit, Laura M Cox, Chaithra Malli, Anitha D’Cunha, Timothy Rooney, Hrishikesh Lokhande, Valerie Willocq, Shrishti Saxena and Tanuja Chitnis

Neurology: Neuroimmunology & Neuroinflammation – January 2021

Neuromyelitis optica testing and treatment: Availability and affordability in 60 countries

Kathryn Holroyd, Andre Vogel, Kat Lynch, Brittany Gazdag, Matthew Voghel, Nicholas Alakel, Bryan N. Patenaude, Horacio Chiong-Rivero and Farrah J. Mateen

Multiple Sclerosis and Related Disorders – August 2019

Induction of myelinating oligodendrocytes in human cortical spheroids

Mayur Madhavan, Zachary S. Nevin, H. Elizabeth Shick, Eric Garrison, Cheryl Clarkson-Paredes, Molly Karl, Benjamin L.L. Clayton, Daniel C. Factor, Kevin C. Allan, Lilianne Barbar, Tanya Jain, Panagiotis Douvaras, Valentina Fossati, Robert H. Miller and Paul J. Tesar

Nature Methods

September 2018